loadpatents
Patent applications and USPTO patent grants for Kunkel; Lori.The latest application filed is for "dosage and administration of anti-erbb3 (her3) monoclonal antibodies to treat tumors associated with neuregulin 1 (nrg1) gene fusions".
Patent | Date |
---|---|
Dosage And Administration Of Anti-erbb3 (her3) Monoclonal Antibodies To Treat Tumors Associated With Neuregulin 1 (nrg1) Gene Fusions App 20220288204 - LELAND; Shawn M. ;   et al. | 2022-09-15 |
Methods of Using Bispecific CD33 and CD3 Binding Proteins App 20210032339 - Evnin; Luke ;   et al. | 2021-02-04 |
Bispecific CD33 and CD3 Binding Proteins App 20210024654 - Ellwanger; Kristina ;   et al. | 2021-01-28 |
Methods of using bispecific CD33 and CD3 binding proteins Grant 10,738,118 - Evnin , et al. A | 2020-08-11 |
Bispecific CD33 and CD3 binding proteins Grant 10,626,190 - Ellwanger , et al. | 2020-04-21 |
Bispecific CD33 and CD3 Binding Proteins App 20180291113 - ELLWANGER; Kristina ;   et al. | 2018-10-11 |
Methods Of Using Bispecific Cd33 And Cd3 Binding Proteins App 20180148507 - EVNIN; Luke ;   et al. | 2018-05-31 |
Bispecific CD33 and CD3 binding proteins Grant 9,803,029 - Ellwanger , et al. October 31, 2 | 2017-10-31 |
Optimized anti-CD30 antibodies Grant 9,574,006 - Lazar , et al. February 21, 2 | 2017-02-21 |
Bispecific CD33 and CD3 Binding Proteins App 20160194409 - ELLWANGER; Kristina ;   et al. | 2016-07-07 |
Bispecific CD33 and CD3 Binding Proteins App 20160002333 - ELLWANGER; Kristina ;   et al. | 2016-01-07 |
Bispecific CD33 and CD3 binding proteins Grant 9,212,225 - Ellwanger , et al. December 15, 2 | 2015-12-15 |
Optimized Anti-CD30 Antibodies App 20120014943 - Lazar; Gregory Alan ;   et al. | 2012-01-19 |
Optimized anti-CD30 antibodies Grant 7,973,136 - Lazar , et al. July 5, 2 | 2011-07-05 |
Optimized Anti-Cd30 Antibodies App 20080267976 - Lazar; Gregory Alan ;   et al. | 2008-10-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.